By Chris Elkins 
Lawsuits involving one of the biggest pharmaceutical companies and one of the most controversial medical devices in the U.S. now are centralized to a single court. Johnson & Johnson is accused of hiding knowledge that its power morcellator could cause an accidental spread of...
By Chris Elkins 
The inventor of Bair Hugger warming blankets is warning of the risk for infections the device could cause when used during orthopedic surgeries. Dr. Scott D. Augustine invented the Bair Hugger warming blanket and introduced it in 1988, but now he is claiming the device is more...
By Chris Elkins 
The lawsuits of families claiming the anti-nausea drug Zofran caused birth defects in their children are now consolidated to a single court in the Eastern District of Pennsylvania. The transfer order issued by the U.S. Judicial Panel on Multidistrict Litigation found sufficient...
By Michelle Llamas 
Lawsuits against Pfizer alleging that its blockbuster cholesterol drug Lipitor (atorvastatin) – a statin taken by millions of Americans – caused Type 2 diabetes continue to mount, as the first bellwether cases in federal multidistrict litigation (MDL) move closer to trial....
By Chris Elkins 
Medical device manufacturer C.R. Bard may have known about its Recovery inferior vena cava (IVC) blood filter’s risks for complications before receiving permission to market it, according to an NBC News investigation. Bard might have also forged a signature on its application...
By Michelle Llamas 
The U.S. Food and Drug Administration (FDA) warned that Type 2 diabetes drugs in the Dipeptidyl peptidase-4 (DPP-4) inhibitors class may cause severe joint pain. A new warning will be added to the labels of all drugs in the class, said the FDA. These medications control blood...
By Chris Elkins 
Testimony from a Johnson & Johnson biochemist revealed the company hid study results linking its antipsychotic drug Risperdal to dangerous hormonal levels from the U.S. Food and Drug Administration. A recent article in New Brunswick Today made testimony from the February...
By Michelle Llamas 
The U.S. Food and Drug Administration (FDA) approved the first drug to treat loss of female sex drive this week. The agency’s approval of Addyi (flibanserin) – dubbed by the media as the “little pink pill” and “female Viagra” – has supporters cheering, calling it a victory for...
By Chris Elkins 
When the U.S. House of Representatives approved the 21st Century Cures Act on July 10, the Food and Drug Administration’s (FDA) ability to protect consumers was one step closer to losing strength. The bill is currently awaiting U.S. Senate approval, but the FDA’s authority took... Page 8 of 17
The independent gateway for the orthopaedic community. Connecting professionals and patients since 1999.